Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1822-1827
Published online before print June 8, 2006, doi: 10.1161/01.STR.0000226741.20629.b2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/7/1822    most recent
01.STR.0000226741.20629.b2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Audebert, H. J.
Right arrow Articles by Haberl, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Audebert, H. J.
Right arrow Articles by Haberl, R. L.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Thrombolysis
Right arrow CT and MRI
Right arrow Acute Cerebral Infarction
Right arrow Intracerebral Hemorrhage

(Stroke. 2006;37:1822.)
© 2006 American Heart Association, Inc.


Original Contributions

Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers

The Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany

Heinrich J. Audebert, MD; Christian Kukla, MD; Bijan Vatankhah, MD; Berthold Gotzler, MD; Johannes Schenkel, MD, MPH; Stephan Hofer, MD; Andrea Fürst, MD Roman L. Haberl, MD

From the Departments of Neurology (H.J.A., C.K., J.S., R.L.H.) and Radiology (B.G.), Städtisches Klinikum München GmbH, Klinikum München-Harlaching, Germany; and Department of Neurology (B.V., A.F.), University of Regensburg; Department of Internal Medicine (S.H.), Klinikum Freising, Germany.

Correspondence to Dr H. Audebert, Department of Neurology, Städtisches Klinikum München GmbH, Klinikum Harlaching, Sanatoriumsplatz 2, 81545 München, Germany. E-mail neuro.audebert{at}khmh.de

Background and Purpose— Systemic thrombolysis is the only therapy proven to be effective for ischemic stroke. Telemedicine may help to extend its use. However, concerns remain whether management and safety of tissue plasminogen activator (tPA) administration after telemedical consultation are equivalent in less experienced hospitals compared with tPA administration in academic stroke centers.

Methods— During the second year of the ongoing Telemedical Pilot Project for Integrative Stroke Care, all systemic thrombolyses in stroke patients of the 12 regional clinics and the 2 stroke centers were recorded prospectively. Patients’ demographics, stroke severity (National Institutes of Health Stroke Scale), frequency of administration, time management, protocol violations, and safety were included in the analysis.

Results— In 2004, 115 of 4727 stroke or transient ischemic attack patients (2.4%) in the community hospitals and 110 of 1889 patients in the stroke centers (5.8%) received systemic thrombolysis. Prehospital latencies were shorter in the regional hospitals despite longer distances. Door to needle times were shorter in the stroke centers. Although blood pressure was controlled more strictly in community hospitals, symptomatic intracerebral hemorrhage rate (7.8%) was higher (P=0.14) than in stroke centers (2.7%) but still within the range of the National Institute of Neurological Disorders and Stroke trial. In-hospital mortality rate was low in community hospitals (3.5%) and in stroke centers (4.5%).

Conclusions— Although with a lower rate of systemic thrombolysis, there was no evidence of lower treatment quality in the remote hospitals. With increasing numbers of tPA administration and growing training effects, the telestroke concept promises better coverage of systemic thrombolysis in nonurban areas.


Key Words: stroke • telemedicine • thrombolysis




This article has been cited by other articles:


Home page
NeurologyHome page
S. Schwab, B. Vatankhah, C. Kukla, M. Hauchwitz, U. Bogdahn, A. Furst, H. J. Audebert, M. Horn, and On behalf of the TEMPiS Group
Long-term outcome after thrombolysis in telemedical stroke care
Neurology, August 28, 2007; 69(9): 898 - 903.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
H. Markus
Improving the outcome of stroke
BMJ, August 25, 2007; 335(7616): 359 - 360.
[Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein and P. M. Rothwell
Primary Prevention and Health Services Delivery
Stroke, February 1, 2007; 38(2): 222 - 224.
[Full Text] [PDF]


Home page
StrokeHome page
R. Lyons and A. G. Rudd
Health Policy and Outcomes 2006
Stroke, February 1, 2007; 38(2): 229 - 231.
[Full Text] [PDF]